Alchemab Therapeutics
Alchemab Therapeutics focuses on developing antibody therapeutics for difficult-to-treat diseases by studying resilient individuals to understand how they overcome these diseases.
- Drug discovery
- Clinical development
- Antibody therapeutics
- Target identification
Locations
Digital Popularity
Social Media
LinkedIn6,876 Followers
Competitors
Exscientia is a technology-driven company focused on AI drug discovery, aiming to revolutionise the pharmaceutical industry through precision medicine.
Company Details
Alchemab Therapeutics is operated by Alchemab Therapeutics Ltd and is a Active company incorporated on 14 August 2019 with the registered office located in London, Greater London. Alchemab Therapeutics Ltd was registered 6 years ago.
Status
Active
Size
Medium
Directors
6
Age
6 years old
Employees
65
Turnover
Unreported
Total Assets
£25.68M
Cash in Bank
£13.33M
Total Liabilities
-£7.91M
Teams
45
19
13
9
6
6
10
Vice President • Joined Feb 2022
Vice President Of Finance • Joined Dec 2024
Senior Vice President Development • Joined Sep 2021
Vice President Of Technology • Joined Jul 2023
Senior Vice President Of Rsearch • Joined Sep 2023
Chief Executive Officer • Joined Sep 2024
Co-founder • Joined Oct 2019
Principal Scientist • Joined Sep 2020
Principal Scientist • Joined Jan 2023
Principal Scientist • Joined Jul 2021
Principal Scientist • Joined Sep 2020
Principal Scientist • Joined Jan 2023
Principal Scientist • Joined Jul 2021
Principal Scientist • Joined Jul 2021
Principal Scientist • Joined Jan 2025
Principal Scientist • Joined Jan 2023
Protein Expression Scientist • Joined Feb 2022
Scientist • Joined Apr 2022
Protein Scientist • Joined Sep 2021
Senior Scientist • Joined Jun 2022
Vice President • Joined Feb 2022
Senior Vice President Development • Joined Sep 2021
Vice President Of Technology • Joined Jul 2023
Chief Executive Officer • Joined Sep 2024
Co-founder • Joined Oct 2019
Chairman Of The Board
Senior Director • Joined Jun 2022
Head Of Operations • Joined Nov 2021
Director Project Management • Joined May 2023
Associate Director, Finance & Accounting • Joined Feb 2022
Senior Vice President Development • Joined Sep 2021
Vice President Of Technology • Joined Jul 2023
CSO • Joined Nov 2019
Principal Bioinformatician • Joined Jan 2023
Associate Director • Joined Jul 2024
Senior Director • Joined Jun 2022
Head Of Operations • Joined Nov 2021
Associate Director, Finance & Accounting • Joined Feb 2022
Director Of Emerging Target Biology • Joined Feb 2022
Vice President • Joined Feb 2022
Associate Project Manager • Joined Jul 2024
Head Of Operations • Joined Nov 2021
Director Project Management • Joined May 2023
Project Management • Joined Oct 2020
CSO • Joined Nov 2019
Vice President • Joined Feb 2022
Associate Director • Joined Jul 2024
Associate Project Manager • Joined Jul 2024
Director Of Business Development • Joined Jan 2022
Director Of Emerging Target Biology • Joined Feb 2022
Business Development • Joined Oct 2024
Vice President Of Finance • Joined Dec 2024
Senior Vice President Of Rsearch • Joined Sep 2023
Chief Corporate Development And Strategy Officer • Joined Jan 2022
Associate Director Of Immunology • Joined Jul 2022
Information Technology Support Team Lead • Joined Sep 2022
Head Of Translational And Clinical Sciences • Joined Apr 2020
IT Support Technician • Joined Jul 2022
Software Engineer • Joined Jan 2025
Information Technology Support Engineer • Joined Oct 2023
Bioinformatician, Antibody Discovery And Target Deconvolution • Joined Oct 2021
View 45 members